BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258,020 | +27.5% | 266,000 | +29.1% | 0.00% | +33.3% |
| Q2 2023 | $202,347 | +17.4% | 206,000 | +22.6% | 0.00% | 0.0% |
| Q1 2023 | $172,365 | -3.9% | 168,000 | -0.6% | 0.00% | 0.0% |
| Q4 2022 | $179,360 | +10.0% | 169,000 | +2.4% | 0.00% | 0.0% |
| Q3 2022 | $163,000 | -4.1% | 165,000 | -4.1% | 0.00% | 0.0% |
| Q2 2022 | $170,000 | -8.1% | 172,000 | -7.0% | 0.00% | 0.0% |
| Q1 2022 | $185,000 | -6.1% | 185,000 | -1.6% | 0.00% | 0.0% |
| Q4 2021 | $197,000 | -4.8% | 188,000 | -6.9% | 0.00% | 0.0% |
| Q3 2021 | $207,000 | -4.6% | 202,000 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $217,000 | +29.9% | 209,000 | +26.7% | 0.00% | 0.0% |
| Q1 2021 | $167,000 | -4.0% | 165,000 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $174,000 | +89.1% | 162,000 | +84.1% | 0.00% | +50.0% |
| Q3 2020 | $92,000 | -13.2% | 88,000 | +1.1% | 0.00% | 0.0% |
| Q2 2020 | $106,000 | +16.5% | 87,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $91,000 | 0.0% | 87,000 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $91,000 | 0.0% | 86,000 | -7.5% | 0.00% | 0.0% |
| Q3 2019 | $91,000 | -7.1% | 93,000 | -1.1% | 0.00% | 0.0% |
| Q2 2019 | $98,000 | +8.9% | 94,000 | +6.8% | 0.00% | 0.0% |
| Q1 2019 | $90,000 | +23.3% | 88,000 | +20.5% | 0.00% | 0.0% |
| Q4 2018 | $73,000 | -26.3% | 73,000 | -21.5% | 0.00% | 0.0% |
| Q3 2018 | $99,000 | – | 93,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |